NTLA - Intellia Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts10101010
Avg. Estimate-0.44-0.66-2.54-2.83
Low Estimate-0.87-0.85-3.25-3.51
High Estimate0.31-0.55-1.52-2.24
Year Ago EPS-0.49-0.56-2.11-2.54
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts991010
Avg. Estimate18.14M7.86M42.29M25.4M
Low Estimate1.3M1.3M5MN/A
High Estimate55M12M87.57M47.57M
Year Ago Sales7.6M7.11M43.1M42.29M
Sales Growth (year/est)138.70%10.50%-1.90%-39.90%
Earnings History3/30/20196/29/20199/29/201912/30/2019
EPS Est.-0.59-0.6-0.62-0.56
EPS Actual-0.49-0.56-0.49-0.57
Difference0.10.040.13-0.01
Surprise %16.90%6.70%21.00%-1.80%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.44-0.66-2.54-2.83
7 Days Ago-0.45-0.67-2.54-2.83
30 Days Ago-0.53-0.67-2.53-2.89
60 Days Ago-0.48-0.66-2.43-2.76
90 Days Ago-0.48-0.66-2.43-2.76
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 Days111N/A
Up Last 30 Days111N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesNTLAIndustrySectorS&P 500
Current Qtr.10.20%N/AN/A-0.08
Next Qtr.-17.90%N/AN/A0.04
Current Year-20.40%N/AN/A-0.02
Next Year-11.40%N/AN/A0.15
Next 5 Years (per annum)30.00%N/AN/A0.06
Past 5 Years (per annum)N/AN/AN/AN/A